You are here

MariTide

Why Amgen's Weight Loss Result Is a Win for Eli Lilly

Motley Fool

Wed, 11/27/24 - 11:30 am

Amgen says obesity drug caused up to 20% weight loss after a year, but shares drop 10%

CNBC

Tue, 11/26/24 - 11:08 am

Amgen speaks out about bone density concerns with obesity drug

Clinical Trials Arena

Thu, 11/14/24 - 10:06 am

Hidden data on obesity prospect wipe $12B off Amgen market cap

Fierce Biotech

Wed, 11/13/24 - 11:10 am

clinical trials

Amgen Whets Investors’ Appetites for MariTide Obesity Data by End of Year

BioSpace

Thu, 10/31/24 - 09:42 am

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.

BioPharma Dive

Fri, 10/11/24 - 11:10 am

Skye Bioscience

Amgen Plans Phase III Program for Next-Gen Obesity Drug Targeting Liver and Kidney Diseases

BioSpace

Thu, 09/5/24 - 11:40 am

5 Obesity Readouts to Watch in the Second Half of 2024

BioSpace

Tue, 08/13/24 - 11:47 am

clinical trials

Terns Pharmaceuticals

Amgen 'encouraged' by weight-loss drug interim data, shares jump

Reuters

Thu, 05/2/24 - 10:19 pm

clinical trials

Amgen’s Weight-Loss Drug Candidate Shows Promise in Early Data

BioSpace

Mon, 02/5/24 - 11:04 pm

clinical trials